Lynda Wilton - Concepedia

Author

Lynda Wilton

Also Known As

L Wilton, L. Wilton, L.W. Wilton, LYNDA WILTON, Lynda W. Wilton, Lynda Wilton, M. Davies, M. Perrio, L. Wilton, L. Wilton

Publications

1.8K

Citations

H-Index

Concepts

All Affiliations

Drug Safety Research Unit University of Portsmouth University of Hong Kong University College London University of Southampton

About

Lynda Wilton is an author at Drug Safety Research Unit specializing in medicine, pharmacotherapy, and pharmacoepidemiology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	15	19	645
2	Public Health	5	5	172
3	Social Sciences	3	3	59
4	Education	1	1	24
5	Health Sciences	1	1	23

Lynda Wilton

Publications

1.7K

Citations

H-Index

Page 1

	Year	Citations
Pregnancy Outcome of Women Using Atypical Antipsychotic Drugs Kate McKenna, Gideon Koren, Maria Tetelbaum, The Journal of Clinical Psychiatry	2005	313
The epidemiology of pharmacologically treated attention deficit hyperactivity disorder (ADHD) in children, adolescents and adults in UK primary care Suzanne McCarthy, Lynda Wilton, Macey L. Murray, BMC Pediatrics	2012	217
Exposure to Mirtazapine During Pregnancy Josephine Djulus, Gideon Koren, Thomas R. Einarson, The Journal of Clinical Psychiatry	2006	138
Salmeterol: A study by Prescription Event Monitoring in a UK cohort of 15,407 patients Ronald D. Mann, Kiyoshi Kubota, Gillian Pearce, Journal of Clinical Epidemiology HypertensionUk CohortPatient SafetyPharmacovigilancePharmacotherapy	1996	108
The safety of finasteride used in benign prostatic hypertrophy: a non‐interventional observational cohort study in 14 772 patients Lynda Wilton, G. L. Pearce, Ekpo Edet, British Journal of Urology	1996	72
Epidemiology and potential associated risk factors of drug-related problems in hospitalised children in the United Kingdom and Saudi Arabia Asia N Rashed, Antje Neubert, Stephen Tomlin, European Journal of Clinical Pharmacology Drug SafetyFamily MedicineSubstance AbusePreventive PediatricsPediatric Epidemiology	2012	69
Epidemiology and potential risk factors of drug‐related problems in <scp>H</scp>ong <scp>K</scp>ong paediatric wards Asia N Rashed, Lynda Wilton, Charles Cheuk Hang Lo, British Journal of Clinical Pharmacology	2013	65
Safety of fluconazole in the treatment of vaginal candidiasis W.H.W. Inman, G. L. Pearce, Lynda Wilton European Journal of Clinical Pharmacology Antifungal AgentVaginal CandidiasisVaginitisAntimicrobial ChemotherapyInfection Control	1994	62
The use of medications with anticholinergic properties and risk factors for their use in hospitalised elderly patients Martin Wawruch, Agata Macugova, Lenka Kostkova, Pharmacoepidemiology and Drug Safety	2011	54
Comparison of the Risk of Drowsiness and Sedation between Levocetirizine and Desloratadine Deborah Layton, Lynda Wilton, A. Boshier, Drug Safety SleepMedicineAnesthesia PracticeNeuropharmacologyPharmacotherapy	2006	45

Page 1